BeyondSpring
BYSI
BYSI
About: BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Employees: 40
0
Funds
holding %
of 7,462 funds
–
Analysts
bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
85% more capital invested
Capital invested by funds: $7.61M [Q1] → $14.1M (+$6.5M) [Q2]
1.73% more ownership
Funds ownership: 13.16% [Q1] → 14.89% (+1.73%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
11% less funds holding
Funds holding: 18 [Q1] → 16 (-2) [Q2]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Financial journalist opinion
Charts implemented using
Lightweight Charts™